Meiqin Tang
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Author Correction: A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.
Journal: Nature communications
Published: April 15, 2026
A proteogenomic atlas of 1032 brain metastases identifies molecular subtypes, immune landscapes, and therapeutic vulnerabilities.
Journal: Nature communications
Published: September 10, 2025
Knockdown of caspase-activated DNase and B-cell lymphoma 2 inhibits cell proliferation and drug resistance in TP53-mutant multiple myeloma.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: June 20, 2025
The BRAF V600E/MEK/ERK/METTL3 positive feedback loop regulates autophagy and promotes stemness and invasiveness in glioblastoma via m6A modification.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 09, 2025
Targeting tumour-neuron synapses with intracavitary RNA delivery prevents glioblastoma recurrence.
Journal: Nature biomedical engineering
Published: March 02, 2025
Structural insights into the activation of TMEM175 by small molecule.
Journal: Neuron
Published: January 06, 2025
Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer.
Journal: International journal of medical sciences
Published: June 23, 2020
Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2-myeloma cell interaction.
Journal: BMC cancer
Published: March 01, 2019
[Corrigendum] MicroRNA‑497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl‑2.
Journal: International journal of molecular medicine
Published: February 02, 2018
MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2.
Journal: International journal of molecular medicine
Published: February 02, 2018
Last Updated: 09/26/2026